newsfilter
← Latest News
Business Wire·

Coya Therapeutics to Participate in Two Upcoming Conferences in May 2025

Coya Therapeutics, Inc. (NASDAQ:COYA) ("Coya" or the "Company"), a clinical-stage biotechnology company developing biologics intended to enhance regulatory T cell (Treg) function, announces that it will participate in